MENU

REPL Replimune Group Forecast, Technical & Fundamental Analysis

Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies... Show more

Industry: #Biotechnology
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
REPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

REPL is expected to report earnings to rise 4.40% to -75 cents per share on October 29

Replimune Group REPL Stock Earnings Reports
Q3'26
Est.
$-0.75
Q2'26
Missed
by $0.07
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.13
The last earnings report on August 14 showed earnings per share of -72 cents, missing the estimate of -64 cents. With 1.00M shares outstanding, the current market capitalization sits at 1.22B.
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
465
Web
https://www.replimune.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HPE62.331.30
+2.13%
Hewlett Packard Enterprise Company
AROC30.840.44
+1.45%
Archrock
NHIC8.64N/A
N/A
Newhold Investment Corp III
TNC65.95-0.77
-1.15%
Tennant Company
ZEO0.40-0.09
-19.01%
Zeo Energy Corp

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with IMNN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then IMNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REPL
1D Price
Change %
REPL100%
-3.79%
IMNN - REPL
57%
Loosely correlated
-2.65%
SNDX - REPL
49%
Loosely correlated
-3.00%
KYMR - REPL
45%
Loosely correlated
-5.40%
NRIX - REPL
43%
Loosely correlated
-6.97%
ZYME - REPL
42%
Loosely correlated
-0.24%
More
Replimune Group (REPL) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com